ResMed has developed a system to provide real-time COPD exacerbation risk notifications by analyzing rescue and controller medication events detected by sensors. The method involves receiving medication events, determining risk levels, and sending notifications to patients and healthcare providers. GlobalData’s report on ResMed gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on ResMed, was a key innovation area identified from patents. ResMed's grant share as of April 2024 was 56%. Grant share is based on the ratio of number of grants to total number of patents.
Real-time copd exacerbation risk notifications based on medication use
A recently granted patent (Publication Number: US11972864B2) outlines a computer-executed method that involves receiving rescue medication events from multiple client computing devices associated with patients, storing these events, and determining real-time risk of an outbreak of rescue medication usage for a geographic region. The method includes applying a machine-learned model to historical and current rescue medication events to assess the risk and transmitting notifications to client devices with relevant information. The system also considers controller medication adherence plans and historical events to further determine the risk of rescue medication usage.
The patent details a comprehensive approach to monitoring and predicting rescue medication usage outbreaks by analyzing data from medicament devices associated with patients. By leveraging machine learning models, historical data, and real-time events, the system can provide accurate risk assessments and timely notifications to patients and healthcare providers. Additionally, the method incorporates controller medication adherence plans to offer a more holistic view of patient medication usage and risk factors. This innovative system aims to enhance patient care by enabling proactive measures to address potential outbreaks of rescue medication usage, ultimately improving overall health outcomes for individuals.
To know more about GlobalData’s detailed insights on ResMed, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
